threonine and Hyperhomocysteinemia

threonine has been researched along with Hyperhomocysteinemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bridge, PJ; Fung, E; Hyndman, ME; Manns, BJ; Parsons, HG; Scott-Douglas, NW; Snyder, FF	1
Chotkowska, E; Dzielińska, Z; Gaździk, D; Janas, J; Kadziela, J; Piotrowski, W; Ruzyłło, W; Szperl, M	1
Allasino, B; Angeli, A; Aroasio, E; Bosio, S; Brusa, E; Camaschella, C; Daffara, F; Reimondo, G; Sacchetto, G; Terzolo, M; Ventura, M	1
Apeland, T; Mansoor, MA; Strandjord, RE	1

Trials

1 trial(s) available for threonine and Hyperhomocysteinemia

Article	Year
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:2 Topics: Cysteine; Genotype; Glycine; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Threonine; Vitamin B 12	2003

Article

Year

Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.

Metabolism: clinical and experimental, 2003, Volume: 52, Issue:2

Topics: Cysteine; Genotype; Glycine; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Threonine; Vitamin B 12

2003

Other Studies

3 other study(ies) available for threonine and Hyperhomocysteinemia

Article	Year
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kardiologia polska, 2003, Volume: 59, Issue:7 Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Cysteine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Threonine; Vitamin B 12	2003
Hyperhomocysteinemia in patients with Cushing's syndrome. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:8 Topics: Adult; Aged; Case-Control Studies; Circadian Rhythm; Cushing Syndrome; Cysteine; DNA; Female; Folic Acid; Homocysteine; Humans; Hydrocortisone; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Osmolar Concentration; Polymorphism, Genetic; Threonine	2004
Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy research, 2001, Volume: 47, Issue:1-2 Topics: Adult; Amino Acid Substitution; Anticonvulsants; Cholesterol; Cholesterol, HDL; Confidence Intervals; Cysteine; Epilepsy; Fasting; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Mutation; Predictive Value of Tests; Prevalence; Statistics, Nonparametric; Threonine; Triglycerides; Vitamin B 12	2001